ATE504588T1 - Stabile salze von olanzapin - Google Patents

Stabile salze von olanzapin

Info

Publication number
ATE504588T1
ATE504588T1 AT05707055T AT05707055T ATE504588T1 AT E504588 T1 ATE504588 T1 AT E504588T1 AT 05707055 T AT05707055 T AT 05707055T AT 05707055 T AT05707055 T AT 05707055T AT E504588 T1 ATE504588 T1 AT E504588T1
Authority
AT
Austria
Prior art keywords
olanzapine
stable salts
salts
stable
Prior art date
Application number
AT05707055T
Other languages
English (en)
Inventor
Rolf Keltjens
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Application granted granted Critical
Publication of ATE504588T1 publication Critical patent/ATE504588T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05707055T 2004-01-27 2005-01-26 Stabile salze von olanzapin ATE504588T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53912004P 2004-01-27 2004-01-27
US56960704P 2004-05-11 2004-05-11
PCT/EP2005/000835 WO2005070938A1 (en) 2004-01-27 2005-01-26 Stable salts of olanzapine

Publications (1)

Publication Number Publication Date
ATE504588T1 true ATE504588T1 (de) 2011-04-15

Family

ID=34811365

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05707055T ATE504588T1 (de) 2004-01-27 2005-01-26 Stabile salze von olanzapin

Country Status (6)

Country Link
US (2) US7459449B2 (de)
EP (1) EP1709053B1 (de)
AR (1) AR047459A1 (de)
AT (1) ATE504588T1 (de)
DE (1) DE602005027308D1 (de)
WO (1) WO2005070938A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074474A2 (en) 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
CA2489984A1 (en) 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
AU2003300324A1 (en) * 2002-12-24 2004-07-22 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
WO2005070938A1 (en) * 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
AR048272A1 (es) * 2004-03-18 2006-04-12 Lek Pharmaceuticals Sintesis de 2 metil - 4- (4- metil -1- piperazinil) - 10 h- tieno ( 2,3-b) (1,5) benzodiazepina y sus sales, metodos para su preparacion, composiciones farmaceuticas que la contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mentales.
WO2007020080A1 (en) * 2005-08-17 2007-02-22 Synthon B.V. A process for making olanzapine form i
PL377084A1 (pl) * 2005-09-15 2007-03-19 Koźluk Tomasz Nobilus Ent Nowe związki olanzapiny i sposób ich wytwarzania
ES2279715B1 (es) * 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
US20070293479A1 (en) * 2006-05-18 2007-12-20 Osinga Niels J Olanzapine pharmaceutical composition
AR063043A1 (es) * 2006-09-29 2008-12-23 Synthon Bv Composicion farmaceutica de olanzapina
BRPI1007173A2 (pt) 2009-01-20 2016-02-23 Los Angeles Biomed Res Inst composição farmacêutica compreendendo ácido sórbico e benzóico e seus derivados que melhora a atividade de um neurofármaco, e seu uso, formulação farmacêutica e método de mitigação de um ou mais sintomas de um distúrbio neuropsiquiátrico
EP2403500A4 (de) * 2009-03-05 2013-12-25 Genepharm India Private Ltd Stabile olanzapintabletten und verfahren zu ihrer herstellung
US11458119B2 (en) 2009-11-27 2022-10-04 Genzyme Corporation Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
CN103211797B (zh) * 2012-01-18 2017-06-06 北京天衡医院管理有限公司 盐酸维拉帕米膜控缓释微丸胶囊
RU2022101542A (ru) 2016-06-13 2022-02-03 Сайньюрекс Интернэшнл (Тайвань) Корп. Сокристаллы бензоата лития и их применения
US11008277B2 (en) 2016-06-13 2021-05-18 Syneurx International (Taiwan) Corp. Co-crystals of sodium benzoate and uses thereof
US11369579B2 (en) 2016-10-24 2022-06-28 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
US10336679B2 (en) 2016-10-24 2019-07-02 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
US10098861B1 (en) 2017-10-24 2018-10-16 Syneurx International (Taiwan) Corp. Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof
IL297915A (en) * 2020-05-05 2023-01-01 Syneurx Int Taiwan Corp Salts of neuroceuticals and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115568A (en) * 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5605897A (en) 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
GB9423511D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
EG23659A (en) 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EP0828494B1 (de) 1995-05-30 2002-07-17 Eli Lilly And Company Verfahren zur behandlung von wahrnehmungsstörungen
ZA978515B (en) 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
HU226167B1 (hu) 1996-09-23 2008-05-28 Lilly Co Eli Olanzapin-dihidrát D, elõállítása és az azt tartalmazó gyógyszerkészítmények
JP2001517684A (ja) * 1997-09-30 2001-10-09 イーライ・リリー・アンド・カンパニー 性機能不全を処置するための方法
JP4503826B2 (ja) 1997-09-30 2010-07-14 イーライ リリー アンド カンパニー ２−メチル−チエノ−ベンゾジアゼピン製剤
US6348458B1 (en) * 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
EP1246827B1 (de) 1999-12-28 2005-04-13 Cipla Limited Neue polymorphe formen von olanzapin
SK2502003A3 (en) 2000-08-31 2004-03-02 Reddys Lab Ltd Dr Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
US6740753B2 (en) * 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
UA80095C2 (en) 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
WO2003091260A1 (en) 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
US7297789B2 (en) 2002-05-31 2007-11-20 Sandoz, Inc. Process of preparation of olanzapine form I
PL199016B1 (pl) 2002-06-20 2008-08-29 Adamed Sp Z Oo Sposób wytwarzania olanzapiny
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
WO2005070938A1 (en) * 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I

Also Published As

Publication number Publication date
EP1709053A1 (de) 2006-10-11
US7329747B2 (en) 2008-02-12
EP1709053B1 (de) 2011-04-06
WO2005070938A1 (en) 2005-08-04
DE602005027308D1 (de) 2011-05-19
US7459449B2 (en) 2008-12-02
AR047459A1 (es) 2006-01-18
US20050272721A1 (en) 2005-12-08
US20050267099A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
ATE504588T1 (de) Stabile salze von olanzapin
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK1720866T3 (da) Fremgangsmåde
DE602005012267D1 (de) N von geräten
DE602005011285D1 (de) Formmasse von polymer
DK1745062T3 (da) Forbedrede modulatorer af koagulationsfaktorer
DK1786472T3 (da) Antisense-modulering af apolipoprotein B-ekspression
DK1846566T3 (da) Stabile nåleformede krystaller af natamycin
ATE532515T1 (de) Stabile laquinimod-zubereitungen
DE602006004463D1 (de) Kristallform von asenapinmaleat
ATE402154T1 (de) Monohydrochloridsalz von 1-ä3-ä3-(4- chlorphenyl)propoxyüpropylüpiperidin
DK1794596T3 (da) Nye stabile lipidstandarder
ATE545642T1 (de) Mmp-inhibitoren
DK1763520T3 (da) Anvendelse af trisubstituerede benzopyranoner
ATE433449T1 (de) Kinaseinhibitoren
DE502006004941D1 (de) Von hohlprofilen
DE502005005664D1 (de) Chronograph
DE602004004638D1 (de) Kalibration von Peak-Pattern
DE602004021352D1 (de) Stabile lipase-varianten
DE602005026256D1 (de) Serien-brückenschaltung
IS7963A (is) Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
DK2301576T3 (da) Terapeutisk anvendelse af anti-CS1-antistoffer
DK1787450T3 (da) Udvælgelse af information
AT6947U3 (de) Bob

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties